Business Standard

Easy to store and cheaper, Oxford's Covid shot may be vaccine for the world

Astra vaccine accounts for more than 40% of supplies going to low- and middle-income nations

Coronavirus, vaccine, covid, drugs, clinical trials
Premium

UK’s approval may soon be followed by other countries, including India, though the European Union and the US are not expected to act on the vaccine anytime soon.

Agencies
AstraZeneca and Oxford’s vaccine developed against Covid-19 can be stored, transported, and handled at normal refrigerator temperatures, making it an attractive option for countries around the world vis-a-vis its counterparts Pfizer and Moderna. 
It is for these reasons that the vaccine proves to be cheaper and easier to administer. 

UK’s approval may soon be followed by other countries, including India, though the European Union and the US are not expected to act on the vaccine anytime soon. AstraZeneca said Wednesday it is seeking an emergency-use listing from the World Health Organization so that the shot can be made available to low- and

Don't miss the most important news and views of the day. Get them on our Telegram channel

First Published: Dec 31 2020 | 2:31 AM IST

Explore News

To read the full story, subscribe to BS Premium now, at just Rs 249/ month.

Key stories on business-standard.com are available only to BS Premium subscribers.

Register to read more on Business-Standard.com